Caglar Yazicioglu

Caglar Yazicioglu

Auto-generated profile, based on publicly available information

Caglar Yazicioglu

Acibadem International Hospital, Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
CYCaglar Yazicioglu
Caglar Yazicioglu
AYAysen Yuceturk
Aysen Yuceturk
OKOzge Karaosmanoglu
Ozge Karaosmanoglu
IAIlke özer aslan
Ilke özer aslan
NPNuri Peker
Nuri Peker
BTBulent Tiras
Bulent Tiras
The endometrioma accompanying hydrosalpinx can affect the success rate of in vitro fertilization (IVF). We aimed to determine the incidence of hydrosalpinx in infertile patients with endometrioma and its effects on in vitro fertilization success. In our retrospective study, we performed hysterosalpingography (HSG) on patients diagnosed with endometrioma through ultrasound evaluation. Then, we performed diagnostic laparoscopy on patients with suspected tubal pathology and/or hydrosalpinx after HSG assessment. Laparoscopic tubal occlusion was performed for patients with hydrosalpinx. HSG was performed on 760 patients diagnosed with ovarian endometriosis. After the assessment of HSG images, hydrosalpinx was detected in 184 of 760 patients (24.2%) and diagnostic laparoscopy was performed. Unilateral or bilateral hydrosalpinx were detected at 65 of 184 (35.3%) patients. Laparoscopy and proximal tubal occlusion were performed in these patients. Incidence of hydrosalpinx was found to be 8.5% in IVF patients with ovarian endometrioma. Tubal patency screening may be considered for the patients with endometrioma before embryo transfer to prevent IVF failure due to hydrosalpinx.

12 December 2024 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
ZKZeynep Ece Utkan Korun
Zeynep Ece Utkan Korun
AYAyşen Yücetürk
Ayşen Yücetürk
ÖKÖzge Karaosmanoğlu
Özge Karaosmanoğlu
ŞKŞule Yıldırım Köpük
Şule Yıldırım Köpük
ÇYÇağlar Yazıcıoğlu
Çağlar Yazıcıoğlu
BTBülent Tıraş
Bülent Tıraş
Cessation of gonadotropin stimulation might affect follicular growth in patients in POSEIDON groups 3 and 4, which are unresponsive to high-dose stimulation. In this retrospective study, data were extracted from the medical records of patients treated at the Acıbadem Maslak Hospital Assisted Reproductive Technologies Unit between November 2010 and December 2020. Eighty-five patients who fulfilled the inclusion criteria were included in the study. Gonadotropin stimulation was discontinued if the follicle diameter increased by 2 mm within 7 days after the initiation of stimulation in patients in groups 3 and 4. The outcomes of the treatment strategy and pregnancy were recorded. Follicular growth was observed in 40% (34/85) of patients, of whom 52.9% (18/34) had 2pn embryos. Ten of the 85 patients (11.8%) underwent embryo transfer, resulting in biochemical pregnancy for two patients and healthy live birth for one patient. When high-dose stimulation is ineffective, discontinuing gonadotropin administration during ovarian stimulation may provide patients with the opportunity to conceive using their own biological oocytes. To the best of our knowledge, this is the first study to report a live birth rate using this strategy.